- 专利标题： Monoclonal antibody therapy for pancreas cancer
-
申请号： US16162731申请日： 2018-10-17
-
公开(公告)号： US11001641B2公开(公告)日： 2021-05-11
- 发明人: Myron Arlen , Kwong Tsang
- 申请人： PRECISION BIOLOGICS, INC.
- 申请人地址： US MD Rockville
- 专利权人： PRECISION BIOLOGICS, INC.
- 当前专利权人： PRECISION BIOLOGICS, INC.
- 当前专利权人地址： US MD Rockville
- 代理机构： Baker, Donelson, Bearman, Caldwell & Berkowitz PC
- 代理商 Robin L. Teskin
- 主分类号： A61K39/00
- IPC分类号： A61K39/00 ; C07K16/30 ; A61K47/68 ; A61K39/395 ; G01N33/574 ; A61K49/04 ; A61K49/16 ; A61K49/22
摘要：
The present invention relates to the use of binding equivalents of monoclonal antibody 31.1, including chimerized and/or humanized versions thereof, antibody fragments as well as competitively binding and co-specific antibodies and antibody fragments, in the treatment of pancreatic cancer.
公开/授权文献
- US20190100601A1 MONOCLONAL ANTIBODY THERAPY FOR PANCREAS CANCER 公开/授权日：2019-04-04
信息查询
